Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
ARTICLE | Financial News

Foghorn launches with $50M for chromatin remodeling platform

March 14, 2018 11:07 PM UTC

Flagship Pioneering's Flagship VentureLabs launched chromatin remodeling company Foghorn Therapeutics Inc. (Cambridge, Mass.) with a $50 million capital commitment. Foghorn's Gene Traffic Control platform identifies small molecules capable of regulating chromatin remodeling complexes, which determine whether particular genes are physically accessible for transcription and eventually expressed as protein.

Foghorn President and CEO Adrian Gottschalk told BioCentury that the initial focus will be on modulating undisclosed components of the SWI/SNF chromatin remodeling complex or its associated transcription factors. The complex is mutated in about 20% of cancers, Gottschalk said...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article